Related references
Note: Only part of the references are listed.Anti-tumor activity of the TGF-β receptor kinase inhibitor galunisertib (LY2157299 monohydrate) in patient-derived tumor xenografts
Armin Maier et al.
CELLULAR ONCOLOGY (2015)
Pharmacokinetic, pharmacodynamic and biomarker evaluation of transforming growth factor-β receptor I kinase inhibitor, galunisertib, in phase 1 study in patients with advanced cancer
Jordi Rodon et al.
INVESTIGATIONAL NEW DRUGS (2015)
Defining a therapeutic window for the novel TGF-β inhibitor LY2157299 monohydrate based on a pharmacokinetic/pharmacodynamic model
Ivelina Gueorguieva et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2014)
Transforming Growth Factor-β as a Therapeutic Target in Hepatocellular Carcinoma
Gianluigi Giannelli et al.
CANCER RESEARCH (2014)
TGF-β inhibition enhances chemotherapy action against triple-negative breast cancer
Neil E. Bhola et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
Differential Inhibition of the TGF-β Signaling Pathway in HCC Cells Using the Small Molecule Inhibitor LY2157299 and the D10 Monoclonal Antibody against TGF-β Receptor Type II
Francesco Dituri et al.
PLOS ONE (2013)
Targeting the TGFβ signalling pathway in disease
Rosemary J. Akhurst et al.
NATURE REVIEWS DRUG DISCOVERY (2012)
Induction of Heart Valve Lesions by Small-Molecule ALK5 Inhibitors
Mark J. Anderton et al.
TOXICOLOGIC PATHOLOGY (2011)
Semi-mechanistic modelling of the tumour growth inhibitory effects of LY2157299, a new type I receptor TGF-beta kinase antagonist, in mice
Lorea Bueno et al.
EUROPEAN JOURNAL OF CANCER (2008)
Transforming growth factor-β signaling in cancer invasion and metastasis
Suvi-Katri Leivonen et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
TGF-β and epithelial-to-mesenchymal transitions
J Zavadil et al.
ONCOGENE (2005)
TGF-β inhibitors for the treatment of cancer
M Lahn et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2005)
Synthesis and activity of new aryl- and heteroaryl- substituted pyrazole inhibitors of the transforming growth factor-b type I receptor kinase domain
JS Sawyer et al.
JOURNAL OF MEDICINAL CHEMISTRY (2003)
TGFβ signaling in growth control, cancer, and heritable disorders
J Massagué et al.
CELL (2000)
Share Paper
